Published in Front Physiol on November 29, 2011
Abnormal cell responses and role of TNF-α in impaired diabetic wound healing. Biomed Res Int (2013) 1.02
Cancer prevention and therapy through the modulation of the tumor microenvironment. Semin Cancer Biol (2015) 0.97
Tendon progenitor cells in injured tendons have strong chondrogenic potential: the CD105-negative subpopulation induces chondrogenic degeneration. Stem Cells (2014) 0.95
ELAVL1 modulates transcriptome-wide miRNA binding in murine macrophages. Cell Rep (2014) 0.92
Pathogenesis of Systemic Sclerosis. Front Immunol (2015) 0.89
Effects of three types of Japanese honey on full-thickness wound in mice. Evid Based Complement Alternat Med (2013) 0.86
The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis. Stem Cell Rev (2015) 0.84
Impaired resolution of inflammation in the Endoglin heterozygous mouse model of chronic colitis. Mediators Inflamm (2014) 0.83
An Essential Role of NRF2 in Diabetic Wound Healing. Diabetes (2015) 0.82
A potential wound-healing-promoting peptide from salamander skin. FASEB J (2014) 0.82
New molecular medicine-based scar management strategies. Burns (2014) 0.81
Receptor-Interacting Protein Kinase 3 Deficiency Delays Cutaneous Wound Healing. PLoS One (2015) 0.79
Leptin effects on the regenerative capacity of human periodontal cells. Int J Endocrinol (2014) 0.79
Impaired wound repair in adult endoglin heterozygous mice associated with lower NO bioavailability. J Invest Dermatol (2013) 0.79
Endoglin haploinsufficiency promotes fibroblast accumulation during wound healing through Akt activation. PLoS One (2013) 0.78
TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms. PLoS One (2015) 0.77
Signaling through the G-protein-coupled receptor Rickets is important for polarity, detachment, and migration of the border cells in Drosophila. Dev Biol (2016) 0.77
Beneficial effects of adiponectin on periodontal ligament cells under normal and regenerative conditions. J Diabetes Res (2014) 0.77
Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction. J Clin Invest (2017) 0.77
Cryptomphalus aspersa Mollusc Egg Extract Promotes Regenerative Effects in Human Dermal Papilla Stem Cells. Int J Mol Sci (2017) 0.75
Comparison of reendothelialization and neointimal formation with stents coated with antibodies against endoglin and CD34 in a porcine model. Drug Des Devel Ther (2015) 0.75
Poly I:C induces collective migration of HaCaT keratinocytes via IL-8. BMC Immunol (2017) 0.75
Zoledronic acid suppresses transforming growth factor-β-induced fibrogenesis by human gingival fibroblasts. Int J Mol Med (2016) 0.75
HDFx: a novel biologic immunomodulator accelerates wound healing and is suggestive of unique regenerative powers: potential implications for the warfighter and disaster victims. Int J Clin Exp Med (2012) 0.75
Vascular precursor cells in tissue injury repair. Transl Res (2017) 0.75
The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08
Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol (2006) 23.04
A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell (2008) 18.18
Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature (1992) 16.46
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med (2003) 13.84
Wound repair and regeneration. Nature (2008) 12.30
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res (1999) 11.32
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A (1993) 10.82
Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol (2009) 7.95
Endothelial progenitor cells: characterization and role in vascular biology. Circ Res (2004) 7.91
Growth factors and cytokines in wound healing. Wound Repair Regen (2009) 7.14
Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature (2005) 6.67
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A (1987) 6.43
A single type of progenitor cell maintains normal epidermis. Nature (2007) 6.32
Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med (2006) 6.21
Formation and function of the myofibroblast during tissue repair. J Invest Dermatol (2007) 6.11
Non-Smad pathways in TGF-beta signaling. Cell Res (2009) 5.54
Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. Cell Stem Cell (2007) 5.28
The regulation of TGFbeta signal transduction. Development (2009) 4.59
The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature (2009) 3.88
Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol (2007) 3.51
Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell (2006) 3.31
Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J (2004) 3.17
Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. Mol Cell (2008) 2.85
Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem (1999) 2.77
Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res (2008) 2.75
Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res (2009) 2.74
Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia (2004) 2.60
Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular lipid storage droplet proteins. J Lipid Res (2009) 2.55
Negative regulation of TGF-beta receptor/Smad signal transduction. Curr Opin Cell Biol (2007) 2.50
How the Smads regulate transcription. Int J Biochem Cell Biol (2007) 2.46
Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis. Circ Res (2008) 2.45
Extrinsic regulation of pluripotent stem cells. Nature (2010) 2.39
Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res (2000) 2.38
Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res (2000) 2.37
Apoptotic cells activate the "phoenix rising" pathway to promote wound healing and tissue regeneration. Sci Signal (2010) 2.36
New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol (2009) 2.34
Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev (2006) 2.15
Endothelial progenitor cells. Annu Rev Med (2005) 2.11
Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem (1990) 2.04
Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J Biol Chem (2002) 1.95
Phospho-control of TGF-beta superfamily signaling. Cell Res (2009) 1.91
Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J (2007) 1.87
Endoglin in angiogenesis and vascular diseases. Angiogenesis (2008) 1.83
Dynamic expression of epidermal caspase 8 simulates a wound healing response. Nature (2009) 1.71
Tgf-Beta signaling in development. Sci STKE (2007) 1.70
Hypoxic induction of endoglin via mitogen-activated protein kinases in mouse brain microvascular endothelial cells. Stroke (2003) 1.70
MCP-1 mediates TGF-beta-induced angiogenesis by stimulating vascular smooth muscle cell migration. Blood (2006) 1.68
Regulating the stability of TGFbeta receptors and Smads. Cell Res (2009) 1.67
Bone morphogenetic proteins and their antagonists in skin and hair follicle biology. J Invest Dermatol (2003) 1.60
Biomechanical regulation of blood vessel growth during tissue vascularization. Nat Med (2009) 1.58
Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders. Chest (2005) 1.57
Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen (2007) 1.56
Epidermal stem cells: the cradle of epidermal determination, differentiation and wound healing. Biol Cell (2005) 1.43
The endoglin(positive) sca-1(positive) rhodamine(low) phenotype defines a near-homogeneous population of long-term repopulating hematopoietic stem cells. Immunity (2003) 1.42
Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. Am J Pathol (2004) 1.39
Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine. Transplant Proc (2006) 1.39
A "traffic control" role for TGFbeta3: orchestrating dermal and epidermal cell motility during wound healing. J Cell Biol (2006) 1.38
Delayed wound healing in immunodeficient TGF-beta 1 knockout mice. J Invest Dermatol (2000) 1.38
Novel biochemical pathways of endoglin in vascular cell physiology. J Cell Biochem (2007) 1.34
CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. Int J Mol Med (2006) 1.34
Endoglin structure and function: Determinants of endoglin phosphorylation by transforming growth factor-beta receptors. J Biol Chem (2006) 1.34
CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci (2003) 1.30
Autocrine transforming growth factor-beta regulation of hematopoiesis: many outcomes that depend on the context. Oncogene (2005) 1.29
Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC. J Biol Chem (2008) 1.27
Involvement of CTGF in TGF-beta1-stimulation of myofibroblast differentiation and collagen matrix contraction in the presence of mechanical stress. Invest Ophthalmol Vis Sci (2004) 1.26
Docosahexaenoic acid alters the size and distribution of cell surface microdomains. Biochim Biophys Acta (2007) 1.26
Epithelial-derived TGF-beta2 modulates basal and wound-healing subepithelial matrix homeostasis. Am J Physiol Lung Cell Mol Physiol (2006) 1.25
Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer (2006) 1.24
Integration of the TGF-beta pathway into the cellular signalling network. Cell Signal (2002) 1.23
Endoglin has a crucial role in blood cell-mediated vascular repair. Circulation (2006) 1.23
Endoglin controls cell migration and composition of focal adhesions: function of the cytosolic domain. J Biol Chem (2004) 1.20
A PDZ-binding motif as a critical determinant of Rho guanine exchange factor function and cell phenotype. Mol Biol Cell (2006) 1.19
Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia. J Mol Biol (2006) 1.17
The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells. J Biol Chem (2007) 1.12
Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflamm Res (2002) 1.12
Down-regulation of CD105 is associated with multi-lineage differentiation in human umbilical cord blood-derived mesenchymal stem cells. Biochem Biophys Res Commun (2009) 1.08
Regulation of TGF-beta signalling by protein phosphatases. Biochem J (2010) 1.08
Transforming growth factor beta1 signalling, wound healing and repair: a multifunctional cytokine with clinical implications for wound repair, a delicate balance. Postgrad Med J (2009) 1.05
The role of Smads in skin development. J Invest Dermatol (2008) 1.04
Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques. Atherosclerosis (2000) 1.04
Angiogenesis, vascular endothelial growth factor and its receptors in human surgical wounds. Br J Surg (2009) 1.04
Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer. Gastric Cancer (2007) 1.03
The environment, epigenetics and amyloidogenesis. J Mol Neurosci (2007) 1.03
Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-beta signaling. J Cell Physiol (2007) 1.02
Endoglin is required for hemangioblast and early hematopoietic development. Development (2007) 1.02
Transforming growth factor-beta and wound healing. Perspect Vasc Surg Endovasc Ther (2006) 1.02
Novel angiogenic signaling pathways and vascular targets. Annu Rev Pharmacol Toxicol (2004) 1.02
Functional significance of Smad2 in regulating basal keratinocyte migration during wound healing. J Invest Dermatol (2005) 1.02
Transforming growth factor-beta and its effect on reepithelialization of partial-thickness ear wounds in transgenic mice. Wound Repair Regen (2005) 1.01
TGF-beta s and TGF-beta type II receptor in human epidermis: differential expression in acute and chronic skin wounds. J Pathol (1993) 0.99
Keratinocyte regulation of TGF-beta and connective tissue growth factor expression: a role in suppression of scar tissue formation. Wound Repair Regen (2007) 0.99
Characterization of human skin-derived mesenchymal stem cell proliferation rate in different growth conditions. Cytotechnology (2009) 0.99
Molecular and developmental biology of the hemangioblast. Dev Dyn (2008) 0.99
Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling. Cell Signal (2010) 0.97
Mesenchymal-epithelial interactions in the skin: aiming for site-specific tissue regeneration. J Dermatol Sci (2005) 0.97
Hemoglobin-derived peptides as novel type of bioactive signaling molecules. AAPS J (2010) 0.97
Characterization of wound drainage fluids as a source of soluble factors associated with wound healing: comparison with platelet-rich plasma and potential use in cell culture. Wound Repair Regen (2007) 0.97
Alpha-smooth muscle actin expression and structure integrity in chondrogenesis of human mesenchymal stem cells. Cell Tissue Res (2006) 0.95
Thrombin induces endocytosis of endoglin and type-II TGF-beta receptor and down-regulation of TGF-beta signaling in endothelial cells. Blood (2004) 0.94
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet (2007) 7.35
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Angiosarcoma. Lancet Oncol (2010) 4.34
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20
Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. J Natl Cancer Inst (2009) 2.88
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst (2004) 2.66
A critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Pathol (2009) 2.24
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res (2013) 1.92
Current methods for assaying angiogenesis in vitro and in vivo. Int J Exp Pathol (2004) 1.88
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 1.56
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet (2013) 1.39
Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev (2009) 1.29
CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. J Clin Oncol (2012) 1.29
The role of genetic breast cancer susceptibility variants as prognostic factors. Hum Mol Genet (2012) 1.23
Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. J Natl Cancer Inst (2010) 1.17
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One (2012) 1.13
Use of macrophages to target therapeutic adenovirus to human prostate tumors. Cancer Res (2011) 1.12
Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity. Breast Cancer Res (2004) 1.10
A role for XRCC2 gene polymorphisms in breast cancer risk and survival. J Med Genet (2011) 1.10
Angiopoietin-1 variant reduces LPS-induced microvascular dysfunction in a murine model of sepsis. Crit Care (2012) 1.08
The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer. Gut (2007) 1.06
Alphastatin, a 24-amino acid fragment of human fibrinogen, is a potent new inhibitor of activated endothelial cells in vitro and in vivo. Blood (2003) 1.04
Increasing readiness to decide and strengthening behavioral intentions: evaluating the impact of a web-based patient decision aid for breast cancer treatment options (BresDex: www.bresdex.com). Patient Educ Couns (2012) 1.04
On the mechanism of loading the PCNA sliding clamp by RFC. Mol Microbiol (2008) 1.01
Osteoprotegerin (OPG)--a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis? Int J Cancer (2006) 1.00
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. Hum Mol Genet (2013) 1.00
The unfolded protein response and cancer: a brighter future unfolding? J Mol Med (Berl) (2007) 1.00
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Res (2014) 0.99
Neuropilins: expression and roles in the epithelium. Int J Exp Pathol (2012) 0.98
Classification and functions of enteroendocrine cells of the lower gastrointestinal tract. Int J Exp Pathol (2011) 0.98
The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis. Photochem Photobiol Sci (2002) 0.97
Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity. Int J Cancer (2007) 0.97
Anti-angiogenic therapy: concept to clinic. Microcirculation (2012) 0.96
9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev (2012) 0.95
Matrix metalloproteinase activity and immunohistochemical profile of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 during human dermal wound healing. Wound Repair Regen (2004) 0.94
Fine-mapping CASP8 risk variants in breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 0.94
Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells. Hum Mol Genet (2005) 0.93
Tissue factor, angiogenesis and tumour progression. Breast Cancer Res (2008) 0.93
Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation. Mol Cancer (2010) 0.92
Neuropilin-1 and neuropilin-2 expression in the adenoma-carcinoma sequence of colorectal cancer. Histopathology (2013) 0.92
Endostatin gene variation and protein levels in breast cancer susceptibility and severity. BMC Cancer (2007) 0.92
Anti-angiogenic drug discovery: lessons from the past and thoughts for the future. Expert Opin Drug Discov (2012) 0.91
Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls. Cancer Epidemiol Biomarkers Prev (2010) 0.91
Angiogenesis induction and regression in human surgical wounds. Wound Repair Regen (2002) 0.90
The role of fibrinogen and related fragments in tumour angiogenesis and metastasis. Expert Opin Biol Ther (2003) 0.90
Approaches to improve angiogenesis in tissue-engineered skin. Wound Repair Regen (2004) 0.89
Expression of class 3 semaphorins and their receptors in human breast neoplasia. Histopathology (2011) 0.89
What influences clinicians' operative preferences for women with breast cancer? An application of the discrete choice experiment. Eur J Cancer (2007) 0.88
Macromolecular leak from extrasplenic lymphatics during endotoxemia. Lymphat Res Biol (2009) 0.87
The number of women who would need to be screened regularly by mammography to prevent one death from breast cancer. J Med Screen (2011) 0.87
ROCK induced inflammation of the microcirculation during endotoxemia mediated by nitric oxide synthase. Microvasc Res (2011) 0.86
Common genetic changes in leiomyosarcoma and gastrointestinal stromal tumour: implication for ataxia telangiectasia mutated involvement. Int J Exp Pathol (2009) 0.85
Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact. Mol Cancer (2009) 0.85
Current status and future prospects for anti-angiogenic therapies in cancer. Expert Opin Drug Discov (2009) 0.85
Development of a reconstructed human skin model for angiogenesis. Wound Repair Regen (2003) 0.84
Ketotifen abrogates local and systemic consequences of rat intestinal ischemia-reperfusion injury. J Gastroenterol Hepatol (2005) 0.84
Internalization and biodistribution of polymersomes into oral squamous cell carcinoma cells in vitro and in vivo. Nanomedicine (Lond) (2010) 0.83
Combination therapy inhibits development and progression of mammary tumours in immunocompetent mice. Breast Cancer Res Treat (2011) 0.83
Reduced vascular response to phenylephrine during exposure to lipopolysaccharide in vitro involves nitric oxide and endothelin 1. Shock (2008) 0.82
Anti-angiogenic properties of ADAMTS-4 in vitro. Int J Exp Pathol (2012) 0.82
Microvascular endothelial cell responses in vitro and in vivo: modulation by zoledronic acid and paclitaxel? J Vasc Res (2010) 0.82
Angiopoietins 1 and 2 and Tie-2 receptor expression in human ductal breast disease. Histopathology (2011) 0.81
FK409 inhibits both local and remote organ damage after intestinal ischaemia. J Pathol (2002) 0.81
Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer. PLoS One (2013) 0.81
Is nitric oxide important in photodynamic therapy? J Photochem Photobiol B (2009) 0.81
Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2. PLoS One (2012) 0.80
7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium. J Med Genet (2011) 0.80
The dose-dependent effects of fentanyl on rat skeletal muscle microcirculation in vivo. Anesth Analg (2003) 0.79
A peptide derived from TIMP-3 inhibits multiple angiogenic growth factor receptors and tumour growth and inflammatory arthritis in mice. Angiogenesis (2013) 0.79
Short-chain fatty acid level and field cancerization show opposing associations with enteroendocrine cell number and neuropilin expression in patients with colorectal adenoma. Mol Cancer (2011) 0.79
Constriction of rat extra-splenic veins to lipopolysaccharide involves endothelin-1. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.78
Selective measurement and manipulation of adhesion forces between cancer cells and bone marrow endothelial cells using atomic force microscopy. Nanomedicine (Lond) (2012) 0.78
Response of the rat cremaster microcirculation to hemorrhage in vivo: differential effects of intravenous anesthetic agents. Shock (2002) 0.78
Effects of hypothermia and rewarming on the mucosal villus microcirculation and survival after rat intestinal ischemia-reperfusion injury. Ann Surg (2002) 0.77
Atorvastatin reduces endotoxin-induced microvascular inflammation via NOSII. Naunyn Schmiedebergs Arch Pharmacol (2015) 0.77
The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivo. PLoS One (2013) 0.77
Intravenous anesthesia inhibits leukocyte-endothelial interactions and expression of CD11b after hemorrhage. Shock (2006) 0.77
Lipopolysaccharide alters vasodilation to atrial natriuretic peptide via nitric oxide and endothelin-1: time-dependent effects. Eur J Pharmacol (2009) 0.77
Quantum dot-conjugated anti-GRP78 scFv inhibits cancer growth in mice. Molecules (2012) 0.77
Prostate cancer cells home to bone using a novel in vivo model: modulation by the integrin antagonist GLPG0187. Int J Cancer (2014) 0.76
LPS abolishes extrasplenic vasoconstriction to atrial natriuretic peptide: the role of NO and endothelin 1. Shock (2008) 0.76
Evaluation of fluorescent plasma markers for in vivo microscopy of the microcirculation. J Vasc Res (2012) 0.75